LAUREN BECKER: Open Payments
NPI 1659518587 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 103 payments from 22 companies in 2025. Trend: 2023 $742 · 2024 $1,448 · 2025 $2,371
Food & beverage: $2,196Education: $175
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $407 |
| UCB, Inc. | 9 | $300 |
| Janssen Biotech, Inc. | 16 | $282 |
| ABBVIE INC. | 13 | $242 |
| Arcutis Biotherapeutics, Inc. | 10 | $189 |
| PFIZER INC. | 7 | $168 |
| Novartis Pharmaceuticals Corporation | 7 | $141 |
| Botanix SB Inc | 4 | $89 |
| LEO Pharma Inc. | 3 | $86 |
| Galderma Laboratories, L.P. | 4 | $83 |
Products named: DUPIXENT, Bimzelx, TREMFYA, Zoryve, SKYRIZI, CIBINQO, COSENTYX, SOFDRA.
Industry payments across UT — which companies pay providers there.
